PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2014

Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 25435005 ↗2014Reported benefit

Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury.

MouseChemical/toxinC57BL/6Malen = 100 mice, five groups of 20; five mice per group sacrificed…Injection, route not statedAfter bleomycin pretreatment; interval not stated

Model: Intratracheal bleomycin (40 mg/ml/kg) induced acute lung injury and pulmonary fibrosis

ACE2-uMSC injection significantly alleviated lung injury and reduced Ashcroft fibrosis scores at 14 and 28 days, lowering MDA, GSSG, TNF-alpha, IFN-gamma, TGF-beta, IL-1, IL-2, IL-6, hydroxyproline, collagen type 1 mRNA, MMPs and TIMPs while increasing SOD, GSH, ACE2 and IL-10. The combined constru…

Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.